Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyMarline G. Harmsen, Joanne A. de Hullu, Katja N. Gaarenstroom et al.|BMC Cancer|2015Cited by 106
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1/2</i> Pathogenic Variant CarriersMiranda P. Steenbeek, Joanne A. de Hullu, Marline G. Harmsen et al.|JAMA Oncology|2021Cited by 78
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of <i>BRCA1/2</i> Pathogenic Variants: Prevalence and Clinical FactorsIris A.S. Stroot, Jan Brouwer, Joost Bart et al.|Journal of Clinical Oncology|2023Cited by 14
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H.D. van Bommel, Joanne A. de Hullu, Miranda P. Steenbeek et al.|Supportive Care in Cancer|2022Cited by 9
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P. Steenbeek, Rosella Hermens, Majke H.D. van Bommel et al.|Gynecologic Oncology|2021Cited by 6